Abstracts

COMPARATIVE ANALYSIS OF HUMAN MICROGLIAL MODELS FOR STUDIES OF HIV REPLICATION

HIV associated neurocognitive disorders (HAND) cause significant morbidity and mortality despite the advent of highly active antiretroviral therapy. A deeper understanding of fundamental molecular mechanisms underlying HIV neuropathogenesis in the central nervous system (CNS) will require relevant model systems. Microglia are resident myeloid cells of the brain that are readily infected by HIV and are…

VALIDATION OF RAPID SEMIQUANTITATIVE LATERAL FLOW ASSAY FOR URINE TENOFOVIR

Objective measurements of antiretroviral adherence may be clinically useful for promoting interventions to improve prevention or treatment outcomes. In people receiving oral antiretrovirals containing tenofovir (TFV), recent adherence is correlated with the concentration of TFV in the urine. The purpose of this study was to validate our newly developed semi-quantitative LFA for urine TFV and…

CSF MARKERS OF AD-RELATED PATHOLOGY AND MEMORY DEFICITS IN OLDER PEOPLE WITH HIV

BACKGROUND: Older people with HIV (PWH) are at-risk for Alzheimer’s disease (AD) and its precursor, amnestic mild cognitive impairment (aMCI). Identifying aMCI among PWH is challenging because memory impairment is also common in HIV-associated neurocognitive disorders (HAND). The neuropathological hallmarks of aMCI/AD are amyloid-42 (A?42) plaque and phosphorylated tau (p-tau) accumulation. We assessed whether the…

INTRANASAL INSULIN IMPROVES ATTENTION AND MEMORY IN PEOPLE WITH HIV

Despite suppression of HIV replication with antiretroviral therapies (ART), cognitive impairment (CI) remain prevalent in virally suppressed people with HIV (VS-PWH). Although the precise mechanisms for these residual CI are not fully understood, there is considerable evidence that brain energy metabolism is progressively impaired in VS-PWH. We hypothesized that intranasal insulin (INI) would enhance brain…

STATIN USE AND COGNITIVE PERFORMANCE IN THE MULTICENTER AIDS COHORT STUDY

Cardiovascular and cerebrovascular ischemic disease risk factors are associated with cognitive impairment in HIV seropositive individuals. Hypercholesterolemia, one such risk factor, is often treated with statin medications. Statin medications have both lipid lowering effect and anti-inflammatory properties, can improve endothelial function, and enhance dynamic blood flow in cerebral small vessels, which could potentially benefit cognitive…